Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/RG7795> ?p ?o }
Showing triples 1 to 85 of
85
with 100 triples per page.
- RG7795 abstract "RG7795 (ANA773 previously) is an experimental oral prodrug of isatoribine developed by Anadys Pharmaceuticals which forms an active metabolite that is an agonist for TLR7. It causes an induction of endogenous type 1 interferons. It is designed to treat hepatitis C. Early clinical trials found it to be well tolerated and to have potent antiviral activity irrespective of viral genotype, viral load, gender or previous response to IFN based therapies.".
- RG7795 casNumber "1174920-78-5".
- RG7795 wikiPageID "33909224".
- RG7795 wikiPageLength "11088".
- RG7795 wikiPageOutDegree "58".
- RG7795 wikiPageRevisionID "706840796".
- RG7795 wikiPageWikiLink 2-5-oligoadenylate_synthase.
- RG7795 wikiPageWikiLink Activating_transcription_factor_2.
- RG7795 wikiPageWikiLink Adverse_effect.
- RG7795 wikiPageWikiLink Agonist.
- RG7795 wikiPageWikiLink C-Jun_N-terminal_kinases.
- RG7795 wikiPageWikiLink CXCL11.
- RG7795 wikiPageWikiLink Category:Anti-hepatitis_C_agents.
- RG7795 wikiPageWikiLink Chemotaxis.
- RG7795 wikiPageWikiLink Clinical_trial.
- RG7795 wikiPageWikiLink Cytokine.
- RG7795 wikiPageWikiLink Dendritic_cell.
- RG7795 wikiPageWikiLink Endosome.
- RG7795 wikiPageWikiLink Eosinophil_granulocyte.
- RG7795 wikiPageWikiLink Eukaryotic_initiation_factor.
- RG7795 wikiPageWikiLink Fever.
- RG7795 wikiPageWikiLink Guanosine.
- RG7795 wikiPageWikiLink Heart.
- RG7795 wikiPageWikiLink Hepatitis_C.
- RG7795 wikiPageWikiLink Hoffmann-La_Roche.
- RG7795 wikiPageWikiLink IRF3.
- RG7795 wikiPageWikiLink Imiquimod.
- RG7795 wikiPageWikiLink Interferon.
- RG7795 wikiPageWikiLink Interferon_type_I.
- RG7795 wikiPageWikiLink Interleukin-1_family.
- RG7795 wikiPageWikiLink Interleukin-1_receptor-associated_kinase.
- RG7795 wikiPageWikiLink Interleukin_12.
- RG7795 wikiPageWikiLink Interleukin_6.
- RG7795 wikiPageWikiLink Internal_ribosome_entry_site.
- RG7795 wikiPageWikiLink Isatoribine.
- RG7795 wikiPageWikiLink JAK-STAT_signaling_pathway.
- RG7795 wikiPageWikiLink Liver.
- RG7795 wikiPageWikiLink MYD88.
- RG7795 wikiPageWikiLink Messenger_RNA.
- RG7795 wikiPageWikiLink Mitogen-activated_protein_kinase.
- RG7795 wikiPageWikiLink Monocyte.
- RG7795 wikiPageWikiLink Myalgia.
- RG7795 wikiPageWikiLink NF-κB.
- RG7795 wikiPageWikiLink Natural_killer_cell.
- RG7795 wikiPageWikiLink Nausea.
- RG7795 wikiPageWikiLink Plasmacytoid_dendritic_cell.
- RG7795 wikiPageWikiLink Prodrug.
- RG7795 wikiPageWikiLink RNA.
- RG7795 wikiPageWikiLink Resiquimod.
- RG7795 wikiPageWikiLink Ribonuclease_L.
- RG7795 wikiPageWikiLink Spleen.
- RG7795 wikiPageWikiLink TANK-binding_kinase_1.
- RG7795 wikiPageWikiLink TLR7.
- RG7795 wikiPageWikiLink TLR8.
- RG7795 wikiPageWikiLink TNF_receptor_associated_factor.
- RG7795 wikiPageWikiLink TRAF3.
- RG7795 wikiPageWikiLink TRAF6.
- RG7795 wikiPageWikiLink T_cell.
- RG7795 wikiPageWikiLink Toll-Interleukin_receptor.
- RG7795 wikiPageWikiLink Topical_medication.
- RG7795 wikiPageWikiLink Tumor_necrosis_factor_alpha.
- RG7795 wikiPageWikiLink Uridine.
- RG7795 wikiPageWikiLinkText "RG7795".
- RG7795 casNumber "1174920".
- RG7795 legalStatus "Investigational".
- RG7795 wikiPageUsesTemplate Template:Drugbox.
- RG7795 wikiPageUsesTemplate Template:Multiple_issues.
- RG7795 wikiPageUsesTemplate Template:Notability.
- RG7795 wikiPageUsesTemplate Template:Orphan.
- RG7795 wikiPageUsesTemplate Template:Update_inline.
- RG7795 subject Category:Anti-hepatitis_C_agents.
- RG7795 hypernym Prodrug.
- RG7795 type ChemicalSubstance.
- RG7795 type Drug.
- RG7795 type Chemical.
- RG7795 type ChemicalObject.
- RG7795 type Thing.
- RG7795 type Q8386.
- RG7795 comment "RG7795 (ANA773 previously) is an experimental oral prodrug of isatoribine developed by Anadys Pharmaceuticals which forms an active metabolite that is an agonist for TLR7. It causes an induction of endogenous type 1 interferons. It is designed to treat hepatitis C. Early clinical trials found it to be well tolerated and to have potent antiviral activity irrespective of viral genotype, viral load, gender or previous response to IFN based therapies.".
- RG7795 label "RG7795".
- RG7795 sameAs Q4750293.
- RG7795 sameAs m.0hnby_9.
- RG7795 sameAs Q4750293.
- RG7795 wasDerivedFrom RG7795?oldid=706840796.
- RG7795 isPrimaryTopicOf RG7795.